# CPG Sec. 455.100 Inert Glandular Preparations *(OTC)*, Inadequate Full Disclosure and Claims - FDA Guidance Document

Source: https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-455100-inert-glandular-preparations-otc-inadequate-full-disclosure-and-claims/4cf67516-f1c7-4250-8ff3-ed1ad517170b

> FDA guidance document: CPG Sec. 455.100 Inert Glandular Preparations *(OTC)*, Inadequate Full Disclosure and Claims. Issue date: May 22, 1987. Get complete insights and analysis.

---

## Details

- Title: CPG Sec. 455.100 Inert Glandular Preparations *(OTC)*, Inadequate Full Disclosure and Claims
- Communication Type: Compliance Policy Guide (CPG)
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Issue Date: 1987-05-22

## Related Documents

- [CPG Sec. 454.100 OTC Ear Drop Preparations](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-454100-otc-ear-drop-preparations/b16e5d40-9457-4377-8fb5-4cd4299c9875)
- [CPG Sec. 420.200 Compendium Revisions and Deletions](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-420200-compendium-revisions-and-deletions/b866bcfb-f0db-415c-a295-177a10dcaef7)
- [CPG Sec. 400.335 Fructose-Containing Drugs](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-400335-fructose-containing-drugs/b2d83802-4ef8-4e27-898d-5cf354f406ab)